Hospital Clinic Universitari de Barcelona

Barcelona 08036

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Newly Diagnosed Glioblastoma

Studies at this site

• A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early